GlassScriptPhysician profile
Yana Cavanagh
NPI 1104189844
$97,868.49
in general payments reported to CMS, 2019-2025
29 companies · $50K in 2025
The $50K reported for 2025 was more than what 97% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $3,554 · 2021: $10K · 2022: $5,780 · 2023: $7,478 · 2024: $21K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $8,195 · Food and Beverage: $4,264 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,626.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,350.00 |
| Travel and Lodging | $8,194.65 |
| Food and Beverage | $4,263.70 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $31,709.87 | 2019-2025 | Visiglide, Single Use Aspiration Needle Na-U200h, Single Use Repositionable Clip |
| Boston Scientific Corporation | $22,905.02 | 2019-2025 | General - Therapies, Overstitch Endoscopic Suturing System, Axios |
| Abbvie INC. | $19,739.57 | 2019-2025 | Creon, Linzess |
| Olympus Corporation | $16,816.14 | 2023-2025 | Gastrointestinal Videoscope, Single Use Repositionable Clip, Evis Exera III Colonovideoscope |
| Olympus Corporation of The Americas | $2,570.78 | 2022-2025 | Evis Exera III Colonovideoscope, Single Use Aspiration Needle Na-U200h |
| Olympus Medical Systems Corporation | $1,744.72 | 2024-2025 | |
| Qol Medical, LLC | $505.29 | 2021-2025 | Sucraid, Sucraid |
| Cook Incorporated | $500.00 | 2024 | |
| Apollo Endosurgery US INC | $176.15 | 2021 | |
| Medtronic, INC. | $147.47 | 2021-2023 | Barrx |
| Evoke Pharma, INC. | $116.12 | 2022-2025 | Gimoti |
| Gilead Sciences, INC. | $113.49 | 2020 | |
| Eisai INC. | $112.26 | 2020 | |
| Erbe USA INC | $95.63 | 2024 | |
| Gyrus Acmi, INC. | $89.44 | 2025 | Endoclot Phs |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $89.29 | 2019 | |
| Tempus Ai, INC | $59.95 | 2024 | |
| Ferring Pharmaceuticals INC. | $53.83 | 2023 | Rebyota |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.70 | 2020-2021 | |
| Amgen INC. | $49.64 | 2025 | Uplizna |
| Braintree Laboratories, INC. | $44.09 | 2022-2023 | Sutab |
| Takeda Pharmaceuticals U.S.A., INC. | $43.99 | 2020-2025 | Entyvio |
| Bayer Healthcare Pharmaceuticals INC. | $27.52 | 2022 | |
| Aimmune Therapeutics, INC. | $21.78 | 2024 | |
| Deciphera Pharmaceuticals INC. | $20.59 | 2025 | |
| Vivus LLC | $17.00 | 2023 | Qsymia |
| Exact Sciences Corporation | $16.03 | 2024 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $15.50 | 2024 | |
| Nestle Healthcare Nutrition INC. | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yana Cavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.